What is HC Wainwright’s Forecast for RNAC Q2 Earnings?
Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Free Report) – Equities research analysts at HC Wainwright lowered their Q2 2025 earnings per share estimates for Cartesian Therapeutics in a research note issued to investors on Monday, May 19th. HC Wainwright analyst M. Kapoor now anticipates that the company will earn ($0.68) per share for the quarter, down […]
Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Free Report) – Equities research analysts at HC Wainwright lowered their Q2 2025 earnings per share estimates for Cartesian Therapeutics in a research note issued to investors on Monday, May 19th. HC Wainwright analyst M. Kapoor now anticipates that the company will earn ($0.68) per share for the quarter, down […]
